Corticosteroid (inhaled, nasal, topical, rectal)
Pregnancy: Considered safe — first-line inhaled steroid in asthma during pregnancy (uncontrolled asthma is more harmful than treatment).
Beclometasone dipropionate
Brand names: Clenil Modulite, Qvar, Fostair (with formoterol), Beconase (nasal), Clipper (rectal)
Adult dose
Dose: Asthma — Clenil: 200 mcg BD (mild) up to 1000 mcg BD (severe). Qvar (extra-fine): 50–400 mcg BD; ~half the Clenil dose for equivalent effect. Allergic rhinitis (Beconase): 100 mcg each nostril BD–QDS. UC distal disease (Clipper 5 mg foam/enema): once daily PR for 4 weeks.
Route: Inhalation / Nasal / Topical / Rectal
Frequency: Variable by indication
Max: 2000 mcg/day (Clenil) or 800 mcg/day (Qvar)
Rinse mouth after inhaler use to reduce oral candidiasis. Qvar is NOT dose-equivalent to Clenil — extra-fine particles double potency.
Paediatric dose
Route: Inhalation
Frequency: BD
≥5 yrs Clenil 100–200 mcg BD; ≥12 yrs adult dose. Qvar licensed ≥12 yrs only. Spacer recommended in children. BNFc.
Clinical pearls
- First-line preventer in asthma at low–moderate doses (BTS/SIGN, NICE NG80).
- Qvar's extra-fine particles deposit further in the small airways — useful in patients with peripheral airway disease; halve the daily dose vs Clenil.
- Fostair (beclometasone + formoterol) can be used as both maintenance AND reliever (MART regimen) — single inhaler simplifies severe asthma.
- Clipper (rectal foam/enema) useful for left-sided UC unresponsive to mesalazine — local effect, minimal systemic absorption.
- Always provide a spacer for MDIs, particularly in children and elderly — improves drug delivery and reduces oropharyngeal deposition.
Contraindications
- Untreated active pulmonary or systemic infection (relative — depending on indication)
- Hypersensitivity
Side effects
- Oral candidiasis (rinse mouth + spacer)
- Dysphonia, sore throat
- Paradoxical bronchospasm (rare)
- Adrenal suppression at high doses (especially >1000 mcg/day)
- Reduced linear growth in children (small, generally not affecting final adult height)
- Cataracts, glaucoma (long-term high-dose)
- Skin thinning, easy bruising
- Behavioural changes in children (irritability, sleep disturbance)
Interactions
- CYP3A4 inhibitors (ritonavir, ketoconazole, clarithromycin): markedly ↑ systemic exposure — risk of Cushingoid effects
- Beta-blockers: ↑ risk of severe asthma exacerbation
Monitoring
- Asthma control test, PEFR
- Growth in children (annual height)
- Adrenal axis if doses >1000 mcg/day or symptoms
Reference: BNFc; BNF 90; BNFc; BTS/SIGN Asthma 158 (2019); NICE NG80; SmPC Clenil/Qvar/Fostair/Clipper. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024